20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding DPP-4 Inhibitors: The Role of Key Intermediates in Treating Type 2 Diabetes

At NINGBO INNO PHARMCHEM CO.,LTD., we are deeply invested in the advancement of treatments for prevalent health conditions, such as type 2 diabetes. A significant class of drugs addressing this condition are Dipeptidyl peptidase-IV (DPP-4) inhibitors, which work by enhancing the body's incretin system to improve glycemic control. The successful development and manufacturing of these vital medications depend heavily on the availability of high-quality pharmaceutical intermediates. One such critical component is (R)-3-Amino-4-(3,4,5-trifluorophenyl)butyric Acid Hydrochloride, a key Sitagliptin API intermediate.

Sitagliptin, a prominent DPP-4 inhibitor, relies on this specific trifluorophenyl butyric acid derivative for its synthesis. The precise chemical structure and stereochemistry of this pharmaceutical synthesis building block are crucial for creating a drug that is both effective and safe. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our intermediate meets the stringent specifications required for producing active pharmaceutical ingredients (APIs) like Sitagliptin. By providing reliable access to this Sitagliptin intermediate, we empower pharmaceutical companies to deliver these essential treatments to patients worldwide.

The mechanism of action for DPP-4 inhibitors involves modulating the levels of incretin hormones, which are naturally produced in the body. This targeted approach offers a valuable therapeutic option for individuals managing type 2 diabetes. The journey of these drugs from chemical synthesis to patient care is complex, with intermediates playing a foundational role. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying the chemical building blocks, like our (R)-3-Amino-4-(3,4,5-trifluorophenyl)butyric Acid Hydrochloride, that make these advancements possible, ultimately contributing to better health outcomes.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Fluorinated Organic Compounds in Modern Drug Discovery: A Case Study

Next: Procurement Insights: Sourcing High-Quality (R)-3-Amino-4-(3,4,5-trifluorophenyl)butyric Acid Hydrochloride for Pharmaceutical Manufacturing

All Rights Reserved